Close

Analyst Ratings for Pacira Pharmaceuticals (PCRX)

PCRX Rating Summary

  |   Expand Research on PCRX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/9/2011 Barclays N/A New Coverage Overweight
(N/A)		 12.00
(N/A)		 8.15
(8.38)		 2.82% Details
3/17/2011 Brean Murray Carret & Co. N/A New Coverage Buy
(N/A)		 N/A
(N/A)		 6.85
(8.38)		 22.34% Details